Asahi Kasei Corporation - AHKSY

AHKSY Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
AHKSY	-0.2	0.3	2.0	5.9	6.4	6.7	-28.6	-36.1	-9.4	30.8
S&P 500	-0.6	-0.5	2.3	7.3	12.1	32.1	27.0	90.7	191.4	33587.3

Compare AHKSY with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	AHKSY
name	Asahi Kasei Corporation
price	14.36
changes percentage	-0.21
change	-0.03
day low	14.36
day high	14.39
year high	15.80
year low	12.14
market cap	9953279854
price avg 50	14.45
price avg 200	13.93
exchange	PNK
volume	3099
avg volume	25887
open	14.39
previous close	14.39
eps	0.68
pe	21.12
earnings announcement	2025-02-04T05:00:00.000+0000
shares outstanding	693125338
timestamp	2024-11-14 20:00:00

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 62.7%

Overall Quarterly Financial Health: 61.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
revenue	2784878000000	2726485000000	2.14
gross profit	849213000000	804769000000	5.52
gross profit ratio	0.3	0.3	3.31
research and development expenses	106597000000	105027000000	1.49
operating expenses	708467000000	676417000000	4.74
interest income	7684000000	3896000000	97.23
interest expense	7448000000	5907000000	26.09
ebitda	218487000000	305003000000	-28.37
ebitdaratio	0.08	0.11	-29.87
operating income	140746000000	128352000000	9.66
operating income ratio	0.05	0.05	7.36
net income	43806000000	-91312000000	147.97
net income ratio	0.02	-0.03	146.97
eps	31.6	-65.84	148.00

Overall Score of Annual Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 2,784,878 million in 2024 from 2,726,485 million in 2023 representing a change of 2.14%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 849,213 million in 2024 from 804,769 million in 2023 representing a change of 5.52%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 106,597 million in 2024 from 105,027 million in 2023 representing a change of 1.49%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Income: Operating income increased to 140,746 million in 2024 from 128,352 million in 2023 representing a change of 9.66%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 43,806 million in 2024 from -91,312 million in 2023 representing a change of 147.97%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 31.6 in 2024 from 31.6 in 2023 representing a change of 148.0%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 708,467 million in 2024 from 676,417 million in 2023 representing a change of 4.74%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 218,487 million in 2024 from 305,003 million in 2023 representing a change of -28.37%. The decrease in EBITDA indicates declined operational efficiency and profitability.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000000000
revenue	735934000000	720732000000	2.11
gross profit	231610000000	213746000000	8.36
gross profit ratio	0.31	0.3	6.12
research and development expenses	0	27768000000	-100.00
operating expenses	184668000000	171499000000	7.68
interest income	2790000000	2807000000	-0.61
interest expense	1989000000	2594000000	-23.32
ebitda	94145000000	-16313000000	677.12
ebitdaratio	0.13	0.12	3.00
operating income	49873000000	42247000000	18.05
operating income ratio	0.07	0.06	15.61
net income	34092000000	-14759000000	330.99
net income ratio	0.05	-0.02	326.22
eps	24.59	-10.65	330.89

Overall Score of Quarterly Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 735,934 million in 2025Q1 from 720,732 million in 2024Q4 representing a change of 2.11%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 231,610 million in 2025Q1 from 213,746 million in 2024Q4 representing a change of 8.36%. This indicates a sales profitability growth, which is a positive sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 94,145 million in 2025Q1 from -16,313 million in 2024Q4 representing a change of 677.12%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 49,873 million in 2025Q1 from 42,247 million in 2024Q4 representing a change of 18.05%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 34,092 million in 2025Q1 from -14,759 million in 2024Q4 representing a change of 330.99%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 24.59 in 2025Q1 from 24.59 in 2024Q4 representing a change of 330.89%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2025Q1 from 27,768 million in 2024Q4 representing a change of -100.0%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 184,668 million in 2025Q1 from 171,499 million in 2024Q4 representing a change of 7.68%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
total assets	3662730000000	3454526000000	6.03
total liabilities	1814105000000	1758520000000	3.16
total equity	1848625000000	1696009000000	9.00
cash and cash equivalents	333498000000	247903000000	34.53
short term investments	-93399000000	3278000000	-2,949.27
long term investments	302921000000	220579000000	37.33
total current assets	1650037000000	1488195000000	10.88
total non current assets	2012693000000	1966331000000	2.36
total current liabilities	914572000000	912163000000	0.26
total non current liabilities	899534000000	846357000000	6.28
common stock	103389000000	103389000000	0.00
retained earnings	1135533000000	1142325000000	-0.59
total debt	955561000000	974748000000	-1.97

Overall Score of Annual Balance Sheet

0.56 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 3,662,730 million in 2024 from 3,454,526 million in 2023 representing a change of 6.03%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 1,848,625 million in 2024 from 1,696,009 million in 2023 representing a change of 9.0%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 333,498 million in 2024 from 247,903 million in 2023 representing a change of 34.53%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 1,650,037 million in 2024 from 1,488,195 million in 2023 representing a change of 10.88%. This indicates a better liquidity position.

  Total Debt: Total Debt decreased to 955,561 million in 2024 from 974,748 million in 2023 representing a change of -1.97%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 1,814,105 million in 2024 from 1,758,520 million in 2023 representing a change of 3.16%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to -93,399 million in 2024 from 3,278 million in 2023 representing a change of -2949.27%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 914,572 million in 2024 from 912,163 million in 2023 representing a change of 0.26%. This indicates a higher short-term debt burden.

  Retained Earnings: Retained Earnings decreased to 1,135,533 million in 2024 from 1,142,325 million in 2023 representing a change of -0.59%. This indicates an accumulated losses.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000000000
total assets	3806906000000	3662730000000	3.94
total liabilities	1860857000000	1814106000000	2.58
total equity	1946049000000	1848625000000	5.27
cash and cash equivalents	359497000000	333498000000	7.80
short term investments	4623000000	4610000000	0.28
long term investments	205047000000	204912000000	0.07
total current assets	1724745000000	1650037000000	4.53
total non current assets	2082161000000	2012693000000	3.45
total current liabilities	1021437000000	914572000000	11.68
total non current liabilities	839420000000	899534000000	-6.68
common stock	103389000000	103389000000	0.00
retained earnings	1144368000000	1135533000000	0.78
total debt	1002792000000	955561000000	4.94

Overall Score of Quarterly Balance Sheet

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 3,806,906 million in 2025Q1 from 3,662,730 million in 2024Q4 representing a change of 3.94%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 1,946,049 million in 2025Q1 from 1,848,625 million in 2024Q4 representing a change of 5.27%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 359,497 million in 2025Q1 from 333,498 million in 2024Q4 representing a change of 7.8%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 4,623 million in 2025Q1 from 4,610 million in 2024Q4 representing a change of 0.28%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 1,724,745 million in 2025Q1 from 1,650,037 million in 2024Q4 representing a change of 4.53%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 1,144,368 million in 2025Q1 from 1,135,533 million in 2024Q4 representing a change of 0.78%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 1,860,857 million in 2025Q1 from 1,814,106 million in 2024Q4 representing a change of 2.58%. This indicates an increase in overall liabilities.

  Total Current Liabilities: Total Current Liabilities increased to 1,021,437 million in 2025Q1 from 914,572 million in 2024Q4 representing a change of 11.68%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 1,002,792 million in 2025Q1 from 955,561 million in 2024Q4 representing a change of 4.94%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
net change in cash	85595000000	4956000000	1,627.10
operating cash flow	295300000000	90804000000	225.21
free cash flow	123346000000	-81354000000	251.62
capital expenditure	-171954000000	-172158000000	0.12
depreciation and amortization	182196000000	176651000000	3.14
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts payables	18630000000	-7949000000	334.37
inventory	-16303000000	-84053000000	80.60
acquisitions net	7320000000	-69125000000	110.59
investments in property plant and equipment	-147705000000	-172158000000	14.20
net cash used for investing activites	-142598000000	-212085000000	32.76
debt repayment	-33673000000	165409000000	-120.36
common stock issued	122000000	208000000	-41.35
common stock repurchased	-12000000	-1415000000	99.15
dividends paid	-49962000000	-48575000000	-2.86
net cash used provided by financing activities	-94331000000	111780000000	-184.39
cash at end of period	333498000000	247903000000	34.53
accounts receivables	-19087000000	8405000000	-327.09
cash at beginning of period	247903000000	242947000000	2.04

Overall Score of Annual Cashflow Statement

0.57 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 85,595 million in 2024 from 4,956 million in 2023 representing a change of 1627.1%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 295,300 million in 2024 from 90,804 million in 2023 representing a change of 225.21%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 123,346 million in 2024 from -81,354 million in 2023 representing a change of 251.62%. This indicates an increase in cash generated after accounting for capital expenditures.

  Accounts Receivables: Accounts Receivables decreased to -19,087 million in 2024 from 8,405 million in 2023 representing a change of -327.09%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to -171,954 million in 2024 from -172,158 million in 2023 representing a change of 0.12%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Payables: The absolute value of Accounts Payables increased to 18,630 million in 2024 from 7,949 million in 2023 representing a change of 334.37%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Dividends Paid: Dividends Paid decreased to -49,962 million in 2024 from -48,575 million in 2023 representing a change of -2.86%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000000000
operating cash flow	41559000000	124368000000	-66.58
free cash flow	-1115000000	79517000000	-101.40
capital expenditure	-42674000000	-44851000000	4.85
depreciation and amortization	44272000000	47271000000	-6.34
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	-1850000000	-195000000	-848.72
accounts payables	-22000000	2009000000	-101.10
inventory	-15200000000	-10374000000	-46.52
acquisitions net	2111000000	276000000	664.86
investments in property plant and equipment	-42674000000	-44851000000	4.85
net cash used for investing activites	-56823000000	-25902000000	-119.38
debt repayment	0	-130922000000	100.00
common stock issued	28000000	0	NaN
common stock repurchased	-3000000	-5000000	40.00
dividends paid	-24981000000	0	NaN
net cash used provided by financing activities	22635000000	-134290000000	116.86
net change in cash	359497000000	-20127000000	1,886.14
cash at end of period	359497000000	333498000000	7.80
cash at beginning of period	0	353625000000	-100.00

Overall Score of Quarterly Cashflow Statement

0.43 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 359,497 million in 2025Q1 from -20,127 million in 2024Q4 representing a change of 1886.14%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Accounts Payables: The absolute value of Accounts Payables decreased to 22 million in 2025Q1 from 2,009 million in 2024Q4 representing a change of -101.1%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to -1,850 million in 2025Q1 from -195 million in 2024Q4 representing a change of -848.72%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 41,559 million in 2025Q1 from 124,368 million in 2024Q4 representing a change of -66.58%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to -1,115 million in 2025Q1 from 79,517 million in 2024Q4 representing a change of -101.4%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -42,674 million in 2025Q1 from -44,851 million in 2024Q4 representing a change of 4.85%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Dividends Paid: Dividends Paid decreased to -24,981 million in 2025Q1 from 0 million in 2024Q4 representing a change of nan%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2024-03-31	2023-03-31	Y/Y change %
FY
calendar year	2024	2023	NaN
revenue per share	2009.08	1965.9	2.20
net income per share	31.6	-65.84	148.00
operating cash flow per share	213.04	65.47	225.38
free cash flow per share	88.99	-58.66	251.70
cash per share	173.21	181.11	-4.36
book value per share	1333.65	1222.89	9.06
tangible book value per share	789.17	691.64	14.10
shareholders equity per share	1308.23	1197.59	9.24
interest debt per share	666.93	681.64	-2.16
market cap	2982702479677.14	2573420753549.28	15.90
enterprise value	3604765479677.14	3300265753549.28	9.23
pe ratio	68.09	-28.18	341.60
price to sales ratio	1.07	0.94	13.47
pocfratio	10.1	28.34	-64.36
pfcf ratio	24.18	-31.63	176.45
pb ratio	1.64	1.55	6.16
ptb ratio	1.64	1.55	6.16
ev to sales	1.29	1.21	6.94
enterprise value over ebitda	16.5	10.82	52.48
ev to operating cash flow	12.21	36.34	-66.41
ev to free cash flow	29.22	-40.57	172.04
earnings yield	0.01	-0.04	141.39
free cash flow yield	0.04	-0.03	230.81
debt to equity	0.51	0.57	-10.60
debt to assets	0.25	0.27	-7.94
net debt to ebitda	2.85	2.38	19.47
current ratio	1.8	1.63	10.58
interest coverage	18.9	21.73	-13.03
income quality	6.74	-0.99	777.88
dividend yield	0.02	0.02	-11.26
payout ratio	1.14	-0.53	314.40
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.04	0.04	-0.63
intangibles to total assets	0.21	0.21	-3.39
capex to operating cash flow	0.58	1.9	-69.29
capex to revenue	0.06	0.06	-2.21
capex to depreciation	0.94	0.97	-3.16
stock based compensation to revenue	0	0	NaN
graham number	964.49	1331.95	-27.59
roic	0.08	0.07	16.19
return on tangible assets	0.02	-0.03	144.84
graham net net	-629.29	-617.19	-1.96
working capital	735465000000	576032000000	27.68
tangible asset value	1093897000000	959222000000	14.04
net current asset value	-164068000000	-270325000000	39.31
invested capital	2343482000000	2184517000000	7.28
average receivables	461594500000	436124500000	5.84
average payables	196906000000	179326000000	9.80
average inventory	660694500000	591401000000	11.72
days sales outstanding	63.31	58.92	7.45
days payables outstanding	40.21	34.29	17.25
days of inventory on hand	128.01	122.04	4.89
receivables turnover	5.77	6.19	-6.94
payables turnover	9.08	10.64	-14.72
inventory turnover	2.85	2.99	-4.66
roe	0.02	-0.05	143.94
capex per share	124.05	124.13	-0.06

• Negative

  ROE: Return on Equity (ROE) increased to 0.02 on 2024-03-31 from -0.05 on 2023-03-31, representing a change of 143.94%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 68.09 on 2024-03-31 from -28.18 on 2023-03-31, representing a change of 341.60%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 1.80 on 2024-03-31 from 1.63 on 2023-03-31, representing a change of 10.58%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.51 on 2024-03-31 from 0.57 on 2023-03-31, representing a change of -10.60%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-06-30 Q1	2024-03-31 Q4	Q/Q change %
AHKSY
calendar year	2025	2024	NaN
revenue per share	530.91	519.94	2.11
net income per share	24.59	-10.65	330.99
operating cash flow per share	29.98	89.72	-66.58
free cash flow per share	-0.8	57.36	-101.40
cash per share	262.68	243.92	7.69
book value per share	1403.9	1333.62	5.27
tangible book value per share	841.97	789.15	6.69
shareholders equity per share	1377.42	1308.2	5.29
interest debt per share	724.86	663.42	9.26
market cap	2817197624217.78	2982760647134.2	-5.55
enterprise value	3460492624217.78	3604823647134.2	-4.00
pe ratio	20.66	-50.52	140.89
price to sales ratio	3.83	4.14	-7.50
pocfratio	67.79	23.98	182.65
pfcf ratio	-2526.63	37.51	-6,835.72
pb ratio	1.48	1.64	-10.30
ptb ratio	1.48	1.64	-10.30
ev to sales	4.7	5.0	-5.99
enterprise value over ebitda	36.76	-220.98	116.63
ev to operating cash flow	83.27	28.99	187.27
ev to free cash flow	-3103.58	45.33	-6,946.03
earnings yield	0.01	-0.0	344.57
free cash flow yield	-0.0	0.03	-101.48
debt to equity	0.53	0.51	3.86
debt to assets	0.26	0.25	5.21
net debt to ebitda	6.83	-38.13	117.92
current ratio	1.69	1.8	-6.41
interest coverage	25.07	16.29	53.96
income quality	1.22	-8.43	114.47
dividend yield	0.01	0	NaN
payout ratio	0.73	0	NaN
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0.04	-100.00
intangibles to total assets	0.2	0.21	-0.70
capex to operating cash flow	1.03	0.36	184.73
capex to revenue	0.06	0.06	-6.82
capex to depreciation	0.96	0.95	1.59
stock based compensation to revenue	0	0	NaN
graham number	873.06	559.82	55.95
roic	0.01	0.0	262.73
return on tangible assets	0.01	-0.01	321.84
graham net net	-553.21	-558.58	0.96
working capital	703308000000	735465000000	-4.37
tangible asset value	1167107000000	1093896000000	6.69
net current asset value	-136112000000	-164069000000	17.04
invested capital	2360916000000	2343482000000	0.74
average receivables	492068000000	476618000000	3.24
average payables	217224500000	208482000000	4.19
average inventory	693507000000	667148500000	3.95
days sales outstanding	61.28	60.32	1.59
days payables outstanding	39.47	37.86	4.27
days of inventory on hand	126.38	120.51	4.87
receivables turnover	1.47	1.49	-1.56
payables turnover	2.28	2.38	-4.10
inventory turnover	0.71	0.75	-4.65
roe	0.02	-0.01	319.38
capex per share	30.79	32.36	-4.85

• Negative

  ROE: Return on Equity (ROE) increased to 0.02 on 2024-06-30 Q1 from -0.01 on 2024-03-31 Q4, representing a change of 319.38%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 20.66 on 2024-06-30 Q1 from -50.52 on 2024-03-31 Q4, representing a change of 140.89%. Indicating an increase in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.69 on 2024-06-30 Q1 from 1.80 on 2024-03-31 Q4, representing a change of -6.41%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.53 on 2024-06-30 Q1 from 0.51 on 2024-03-31 Q4, representing a change of 3.86%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 0.89 which is lower than current price 14.36, indicates the company may be overvalued.